Search Results 441-450 of 10166 for SC

  1. A Study to Evaluate the Effectiveness and Safety of Lanadelumab for Prevention Against Acute Attacks of Non-histaminergic Angioedema in Adolescents and Adults - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness of repeated subcutaneous (SC) administrations of Lanadelumab in preventing angioedema ...

  2. Epigenomics and Spatial Biology Core - Mayo Clinic Research

    Single cell (sc) ATAC-seq. Single-cell ATAC-seq combined with gene expression (scATAC+GEX). Single-cell GEX Flex, a single-cell transcriptome assay for ...

  3. Publications - Pablo Moreno Franco, M.D. - Mayo Clinic

    ... SC, Pollock BD. Exploring COVID-19 census burdens by US hospital characteristics: Implications of quality reporting at rural and critical access hospitals ...

  4. Seizures - Diagnosis and treatment - Mayo Clinic

    Schachter SC. Evaluation and management of the first seizure in adults. https://www.uptodate.com/contents/search. Accessed July 31, 2024. AskMayoExpert ...

  5. Celiac disease - Symptoms and causes - Mayo Clinic

    In this digestive condition, gluten in food damages the small intestine, making it hard to absorb nutrients and causing a variety of symptoms.

  6. A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Depemokimab in Adults With Hypereosinophilic Syndrome (HES) - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness of depemokimab 200 mg subcutaneous (SC) given every 6 months versus placebo in participants with ...

  7. #FlashbackFriday 1986: Opening the Florida campus - Mayo Clinic News Network

    Johnson, chairman and chief executive officer of S.C. Johnson & Son, Inc., and chairman of the Mayo Foundation Board of Trustees; and J.E. Davis of ...

  8. Chemotherapy Clinical Trials - Mayo Clinic Research

    The purpose of this Phase 1a/1b study of SC-003 in patients with platinum-resistant/refractory ovarian cancer is to characterize the safety and tolerability of ...

  9. Omalizumab (subcutaneous route) - Mayo Clinic

    Omalizumab injection is used to treat moderate to severe persistent allergic asthma. It is used when a patient's asthma has not been controlled sufficiently on ...

  10. Publications - Siddhartha Yadav, M.B.B.S., M.D. - Mayo Clinic

    Gonzalez-Bosquet J, Shahi M, Yadav S, Kanwar N, Alvand S, Sosa C, Dowdy SC, Halling KC, Weroha SJ, Bakkum-Gamez JN, Podratz KC. ECPPF stratification ...